InspireMD Inc Share Price Nyse
Equities
US45779A3095
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
||
- USD | - |
14/05 | Transcript : InspireMD, Inc., Q1 2024 Earnings Call, May 14, 2024 | |
14/05 | Earnings Flash (NSPR) INSPIREMD Posts Q1 Revenue $1.5M, vs. Street Est of $1.9M | MT |
Sales 2024 * | 69.7L 58Cr | Sales 2025 * | 1.06Cr 89Cr | Capitalization | 5.97Cr 498Cr |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | 8.56 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 5.63 x |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 82.64% |
Latest transcript on InspireMD Inc
Managers | Title | Age | Since |
---|---|---|---|
Marvin Slosman
CEO | Chief Executive Officer | 60 | 01/20/01 |
Craig Shore
DFI | Director of Finance/CFO | 62 | 31/11/31 |
Juan Rigla
CTO | Chief Tech/Sci/R&D Officer | - | 01/14/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Gary Roubin
BRD | Director/Board Member | 75 | 13/20/13 |
Marvin Slosman
CEO | Chief Executive Officer | 60 | 01/20/01 |
Thomas Kester
BRD | Director/Board Member | 77 | 06/16/06 |
1st Jan change | Capi. | |
---|---|---|
+12.62% | 13TCr | |
-1.99% | 1.18TCr | |
+53.19% | 664.78Cr | |
-23.60% | 664.65Cr | |
-30.75% | 418.54Cr | |
-19.96% | 245.95Cr | |
-17.14% | 193.86Cr | |
-21.05% | 174.87Cr | |
-37.13% | 145.35Cr |